Susquehanna International Group’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-26,600
Closed -$30K 10933
2018
Q2
$30K Buy
+26,600
New +$39.8K ﹤0.01% 9377
2018
Q1
Sell
-37,300
Closed -$63K 10880
2017
Q4
$63K Buy
37,300
+29,317
+367% +$60.7K ﹤0.01% 8851
2017
Q3
$20K Buy
7,983
+3,033
+61% +$10.3K ﹤0.01% 8651
2017
Q2
$19K Buy
+4,950
New +$16.9K ﹤0.01% 9032
2016
Q4
Sell
-26,633
Closed -$94K 10655
2016
Q3
$94K Buy
26,633
+14,133
+113% +$64.8K ﹤0.01% 7966
2016
Q2
$167K Sell
12,500
-917
-7% -$15.2K ﹤0.01% 7756
2016
Q1
$216K Buy
13,417
+6,267
+88% +$85.6K ﹤0.01% 7843
2015
Q4
$114K Sell
7,150
-3,083
-30% -$52.9K ﹤0.01% 8819
2015
Q3
$146K Sell
10,233
-1,650
-14% -$28K ﹤0.01% 8943
2015
Q2
$265K Buy
11,883
+450
+4% +$11.3K ﹤0.01% 8769
2015
Q1
$231K Sell
11,433
-24,350
-68% -$453K ﹤0.01% 8426
2014
Q4
$588K Buy
35,783
+2,616
+8% +$40.8K ﹤0.01% 6925
2014
Q3
$505K Sell
33,167
-650
-2% -$12.8K ﹤0.01% 7194
2014
Q2
$848K Buy
33,817
+2,717
+9% +$61.9K ﹤0.01% 6397
2014
Q1
$651K Buy
31,100
+22,867
+278% +$811K ﹤0.01% 6296
2013
Q4
$310K Buy
+8,233
New +$150K ﹤0.01% 7533

Other funds holding CYTR

Susquehanna International Group's CYTR Position: Q4 2017 in Review

Susquehanna International Group sold out of CytRx Corp (CYTR) in Q4 2017, closing a stake of 6,782 shares — an estimated $14K sold.

Susquehanna International Group first reported a position in CYTR in Q4 2013 and held it in 14 quarters. The position peaked at $1.88M in Q1 2014. 33 funds tracked by Wall St. Rank hold CYTR as of Q4 2017.

  • Susquehanna International Group reported no remaining CytRx Corp position as of Q4 2017 after selling out during the quarter.
  • Susquehanna International Group sold 6,782 CytRx Corp shares in Q4 2017, an estimated $14K.
  • Susquehanna International Group first reported a position in CytRx Corp in Q4 2013 and held it in 14 quarters.
  • Susquehanna International Group's CytRx Corp position peaked at $1.88M in Q1 2014.
  • 33 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.